15/03/201926/01/2024 Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update admin 0 Comments
07/03/201926/01/2024 First Patient Dosed in a Phase II Randomized Study of L-DOS47 With Vinorelbine and Cisplatin admin 0 Comments
27/02/201926/01/2024 Helix BioPharma Corp. and Moffitt Cancer Center to Present at the AACR Annual Meeting 2019 in Atlanta admin 0 Comments
11/02/201926/01/2024 Helix BioPharma Corp. Provides Clinical Development and Strategic Corporate Update admin 0 Comments
28/12/201826/01/2024 Helix BioPharma Corp. Closes Final Tranche of Private Placement admin 0 Comments
21/12/201826/01/2024 Helix BioPharma Corp. Closes Third Tranche of Private Placement admin 0 Comments
20/12/201826/01/2024 Helix BioPharma Corp. Closes Second Tranche of Private Placement admin 0 Comments
14/12/201826/01/2024 Helix BioPharma Corp. Announces Fiscal First Quarter 2019 Results admin 0 Comments